Terry-Ann Burrell - Jan 31, 2022 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: CFO
Signature: By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol: BEAM
Transactions as of: Jan 31, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/2/2022, 05:00 PM
Previous filing: Jan 5, 2022
Next filing: Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BEAM	Stock Option (Right to Buy)	Award	$0	+30K		$0.00	30K	Jan 31, 2022	Common Stock	30K	$69.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with Beam Therapeutics Inc. through each vesting date. Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Content

The option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with Beam Therapeutics Inc. through each vesting date. Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.